Live Broadcast to Explore a Second Line Treatment Option for HER2+ Metastatic Breast Cancer

In an upcoming broadcast, Joyce O'Shaughnessy, MD, Shanu Modi, MD, and Anne O’Dea, MD will discuss the approach and goals of the management of certain patients with HER2+ metastatic breast cancer (mBC) and take a deeper look at the burden and unmet needs of the disease. Additionally, they will discuss a second line treatment option for HER2+ mBC.

To obtain expert perspective and learn about the efficacy and safety data of this treatment option, watch the live broadcast on 6/16/2022. To register for the event, visit https://studio.mjhassoc.com/reach/2L-HER2Pos-mBC.

PP-US-ENB-1270 05/22